Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yuma Medical is a clinical-stage medical device company focused on developing innovative transcatheter solutions for structural heart disease. The company's primary focus is the development of a transcatheter tricuspid valve replacement (TTVR) system designed to treat patients suffering from severe tricuspid regurgitation. By utilizing a minimally invasive approach, Yuma Medical aims to provide a safer and more effective alternative to traditional open-heart surgery for high-risk patients. The company is led by experienced professionals in the cardiovascular space and is actively advancing its technology through clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yuma Medical.